Nestin expression in ganglioglioma

Experimental Neurology

Volumn 174, Issue 1, 2002, Pages 89-95

  Duggal, Neil ^a   Hammond, Robert R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cytoskeletal proteins; Epilepsy; Ganglioglioma; MAP2; Nestin

Indexed keywords

NESTIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CHILD; CYTOSKELETON; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; NEUROEPITHELIUM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036123837     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7838     Document Type: Article

References (57)

1. An immunocytochemical and biochemical study of the microtubule-associated protein MAP-2 during postlesion dendritic remodeling in the central nervous system of adult rats
2. Intracranial ganglioglioma: MR, CT, and clinical findings in 18 patients
3. On certain small tumors encountered in the temporal lobe
4. MAP-2 expression and neuritic outgrowth and branching are coregulated through region-specific neuro-astroglial interactions
5. Reactive astrocytes express the embryonic intermediate neurofilament nestin
6. Ganglioglioma. Tumor of the central nervous system: Review of the literature and report of two cases
7. Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology
8. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity
9. Expression of the class VI intermediate filament nestin in human central nervous system tumours
10. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system
11. Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma). A case report and review of the literature
12. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma
13. Inhibition of MAP2 expression affects both morphological and cell division phenotypes of neuronal differentiation
14. Nestin expression in reactive astrocytes following focal cerebral ischemia in rats
15. Ganglioside-enhanced neurite growth: Evidence for a selective induction of high-molecular-weight MAP-2
16. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
17. Rapid, widespread, and long lasting induction of nestin contributes to the generation of glial scar tissue after CNS injury
18. Gangliogliomas in children: A clinicopathological study
19. Anaplastic ganglioglioma of the brain stem demonstrating active neurosecretory features of neoplastic neuronal cells
20. Identification of major cell classes in the developing mammalian nervous system
21. Pathology of temporal lobectomy for refractory seizures in children: Review of 20 cases including some unique malformative lesions
22. Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components: Report of a case with flow cytometric and cytogenetic analysis
23. Gangliogliomas: Pathological and clinical correlation
24. Ganglioglioma: A correlative clinicopathological and radiological study of ten surgically treated cases with follow up
25. Malignant ganglioglioma of the spinal cord
26. The new WHO classification of brain tumors
27. Gangliogliomas: A clinicopathological study of 25 cases and review of the literature
28. Central nervous system gangliogliomas. Part 2. Clinical outcome
29. CNS stem cells express a new class of intermediate filament protein
30. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors
31. Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors
32. Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody
33. Ganglioglioma in children: A review of 32 cases at the University of Florida
34. Central nervous system gangliogliomas. Part 1. Pathology
35. Neuropathological findings in 224 patients with temporal lobe epilepsy
36. Co-existence of neoplasia and cortical dysplasia in patients presenting with seizures
37. Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: A study of 60 patients with intracranial tumors
38. A light- and electron-microscopic study of a temporal lobe ganglioglioma
39. A case with a long history and malignant evolution
40. Gangliogliomas experience with 34 patients and review of the literature
41. Ganglioglioma: A clinical study with long-term follow-up
42. Paraganglioglioma of the cauda equina region. Clinicopathologic study of 31 cases with special reference to immunocytology and ultrastructure
43. Ultrastructural alterations of neuronal cells in a brainstem ganglioglioma
44. Neuroendocrine markers in central nervous system neuronal tumours (gangliocytoma and ganglioglioma)
45. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells
46. Temporal lobe ganglioglioma in children
47. Diffuse leptomeningeal involvement by a ganglioglioma in a child
48. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies
49. Ganglioglioma: A detailed histopathological and immunohistochemical analysis of 61 cases
50. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies
51. Surgical pathology of chronic epileptic seizure disorders
52. Expression of neuronal and glial polypeptides during histogenesis of the human cerebellar cortex including observations on the dentate nucleus
53. Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia
54. Gangliogliomas: Clinical, radiological and histopathological findings in 51 patients
55. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors
56. Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas